Hamdard Laboratories (Waqf) Bangladesh wins at Healthcare Asia Pharma Awards 2026

The recognition highlights a service approach that connects healthcare, education, and ethical practices in Bangladesh.

Hamdard Laboratories (Waqf) Bangladesh has been honoured with the “Most Differentiated Service of the Year – Bangladesh” at the Healthcare Asia Pharma Awards 2026. This prestigious recognition highlights the organisation’s unique service model, which seamlessly integrates healthcare, education, and ethical practices across Bangladesh.

The award acknowledges Hamdard’s innovative and integrated healthcare and wellness ecosystem—one that brings together traditional medicine, consumer wellness, and institutional development under a unified vision. Moving beyond conventional pharmaceutical manufacturing, Hamdard has positioned itself as a comprehensive wellness institution.

Hamdard Laboratories (Waqf) Bangladesh combines Unani, Ayurvedic, and herbal healthcare systems with modern planning, consumer insights, and coordinated operations spanning healthcare services, manufacturing, and education. This integrated approach reflects a forward-looking model that blends tradition with modernity.

The organisation operates a wide-reaching network of institutions, including its state-of-the-art manufacturing plant, Hamdard General Hospital, which provides comprehensive healthcare services under one roof; around 300 healthcare centres across Bangladesh offering free medical consultations; Hamdard University Bangladesh; and several other academic institutions. Together, these entities create a unified framework where healthcare delivery, knowledge development, and consumer wellness products reinforce one another.

Through this model, Hamdard continues to expand its nature-based consumer healthcare portfolio, introducing preventive wellness solutions rooted in nutrition, culture, and traditional medicine. Alongside its strong domestic presence, Hamdard Bangladesh is also expanding internationally, exporting its products to multiple countries.

Behind this success lies strong and visionary leadership. For over five decades, Dr Yousuf Harun Bhuiyan, Chief Mutawalli and Managing Director, has led Hamdard with unwavering integrity, discipline, and dedication. Under his stewardship, the organisation has grown from humble beginnings to a leading position in the industry. Over time, he has become a symbol of trust, credibility, and commitment.

At the same time, Hamdard’s legacy continues to evolve. A new phase of transformation began under the leadership of Professor Kamrun Nahar Harun, who heads the Planning and Marketing Department. Her dynamic leadership has driven significant progress in strategy, organisational structure, branding, communication, innovation, and market engagement.

A defining feature of Hamdard Laboratories (Waqf) Bangladesh is its strong linkage between commercial success and social impact. Unlike profit-centric organisations, Hamdard operates with a mission-driven philosophy. Revenue generated supports hospitals, free medical camps, universities, colleges, research programmes, and a wide range of social welfare initiatives. This ensures that every product and service contributes meaningfully to public health, education, and community development.

By aligning healthcare delivery, manufacturing excellence, and academic advancement, Hamdard has built a sustainable ecosystem that connects treatment, prevention, education, and wellness—ultimately serving the long-term interests of society

The Healthcare Asia Pharma Awards shines a spotlight on the outstanding companies redefining pharmaceutical excellence in Asia. It lauds those who redefine the pharmaceutical landscape through innovative, unique initiatives that have significantly enhanced their businesses.

The Healthcare Asia Pharma Awards is presented by Healthcare Asia Magazine. To view the full list of winners, click here. If you want to join the 2027 awards programme and be recognised for your organisation's innovative and unique initiatives that enhanced your business and remarkable contributions to the pharmaceutical industry, please contact Julie Anne Nuñez-Difuntorum at [email protected].